122 related articles for article (PubMed ID: 7513437)
1. [New prospective therapy for benign prostatic hyperplasia with finasteride].
Miano L; Manieri C; Paradiso Galatioto G; Vicentini C
Riv Eur Sci Med Farmacol; 1993; 15(2):111-9. PubMed ID: 7513437
[TBL] [Abstract][Full Text] [Related]
2. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
Gormley GJ; Stoner E; Bruskewitz RC; Imperato-McGinley J; Walsh PC; McConnell JD; Andriole GL; Geller J; Bracken BR; Tenover JS
N Engl J Med; 1992 Oct; 327(17):1185-91. PubMed ID: 1383816
[TBL] [Abstract][Full Text] [Related]
3. [Finanseride in symtomatic benign prostatic hyeprtrophy. A 2-year placebo-controlled study].
Andersen JT; Wolf H; Ekman P; Beisland HO; Johansson JE; Kontturi M; Lehtonen T; Tveter K
Ugeskr Laeger; 1996 Sep; 158(36):5030-5. PubMed ID: 8928243
[TBL] [Abstract][Full Text] [Related]
4. Finasteride following balloon dilatation of the prostate. A double-blind, placebo-controlled, multicenter study.
Lukkarinen O; Lehtonen T; Talja M; Lundstedt S; Tiitinen J; Taari K
Ann Chir Gynaecol; 1999; 88(4):299-303. PubMed ID: 10661828
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. The Finasteride Study Group.
Stoner E
Arch Intern Med; 1994 Jan; 154(1):83-8. PubMed ID: 7505563
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of benign prostatic hyperplasia with finasteride. Results after 7 years of follow-up].
Martínez Sarmiento M; Cuñat Albert E; López Alcina E; Pontones Moreno JL; Sanz Chinesta S; Jiménez Cruz JF
Actas Urol Esp; 1997 Feb; 21(2):105-10. PubMed ID: 9214205
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of benign prostatic hyperplasia with Proscar (finasteride). Results of a 10-year Scandinavian study].
Tveter KJ; Beisland HO; Andersen JT; Wolf H; Ekman P; Johansson JE; Kontturi M; Lehtonen T
Tidsskr Nor Laegeforen; 1996 Nov; 116(27):3226-30. PubMed ID: 9011975
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term administration of finasteride (MK-906), an inhibitor of 5 alpha-reductase, in patients with benign prostatic hyperplasia.
Yoshida O; Oishi K; Okada Y; Mizutani Y; Itokawa Y; Tomoyoshi T; Okada K; Komatz Y; Matsuda T; Takeuchi H
Hinyokika Kiyo; 1996 Apr; 42(4):323-31. PubMed ID: 8693970
[TBL] [Abstract][Full Text] [Related]
9. 5alpha-reductase inhibitors/finasteride.
Stoner E
Prostate Suppl; 1996; 6():82-7. PubMed ID: 8630236
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study.
Anwarul Islam AK; Kashem MA; Shameem IA; Kibria SA
Bangladesh Med Res Counc Bull; 2005 Aug; 31(2):54-61. PubMed ID: 16967810
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.
Nickel JC; Fradet Y; Boake RC; Pommerville PJ; Perreault JP; Afridi SK; Elhilali MM
CMAJ; 1996 Nov; 155(9):1251-9. PubMed ID: 8911291
[TBL] [Abstract][Full Text] [Related]
12. Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasia.
Magoha GA
East Afr Med J; 1998 May; 75(5):260-3. PubMed ID: 9746993
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment of benign prostatic hyperplasia with finasteride: a clinical review.
Ekman P
Arch Esp Urol; 1994 Nov; 47(9):883-7; discussion 887-8. PubMed ID: 7530944
[TBL] [Abstract][Full Text] [Related]
14. Finasteride in the treatment of benign prostatic hyperplasia.
Ekman P; Andersen JT; Wolf H
Acta Urol Belg; 1996 Mar; 64(1):IX-XII. PubMed ID: 8659328
[TBL] [Abstract][Full Text] [Related]
15. [Finasteride in the treatment of benign prostatic hypertrophy].
Ekman P
J Urol (Paris); 1993; 99(6):299-302. PubMed ID: 7516372
[TBL] [Abstract][Full Text] [Related]
16. [Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume].
Granados Loarca EA
Arch Esp Urol; 1999 Apr; 52(3):201-8. PubMed ID: 10371735
[TBL] [Abstract][Full Text] [Related]
17. Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.
Roehrborn CG; Bruskewitz R; Nickel JC; McConnell JD; Saltzman B; Gittelman MC; Malek GH; Gottesman JE; Suryawanshi S; Drisko J; Meehan A; Waldstreicher J;
J Urol; 2004 Mar; 171(3):1194-8. PubMed ID: 14767299
[TBL] [Abstract][Full Text] [Related]
18. [Effect of dutasteride on reduction of plasma DHT following finasteride therapy in patients with benign prostatic hyperplasia].
Botto H; Lan O; Poulain JE; Comenducci A
Prog Urol; 2005 Dec; 15(6):1090-5. PubMed ID: 16429658
[TBL] [Abstract][Full Text] [Related]
19. [Finasteride (Proscar) for benign prostatic hypertrophy].
Matzkin H; Chen J; Braf Z
Harefuah; 1993 Dec; 125(12):453-6, 496. PubMed ID: 7509305
[TBL] [Abstract][Full Text] [Related]
20. One-year experience in the treatment of benign prostatic hyperplasia with finasteride. The MK-906 (Finasteride) Study Group.
J Androl; 1991; 12(6):372-5. PubMed ID: 1722792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
